Position in RNA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$602,853
New position
Shares Held
45,090
first reported quarter
Ownership
0.264%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026ODDO BHF ASSET MANAGEMENT SAS holds $168,140,352 across 13 Biotechnology names. RNA ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DAWN |
Day One Biopharmaceuticals, Inc.
|
1,550,000 | $33,232,000 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
825,000 | $33,189,750 | |
| 3 | ASND |
Ascendis Pharma A/S
|
128,657 | $29,427,715 | |
| 4 | ARGX |
Argenx SE
|
25,009 | $18,262,822 | |
| 5 | ACLX |
Arcellx, Inc.
|
115,000 | $13,204,300 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,013 | $10,923,011 | |
| 7 | FOLD |
AMICUS THERAPEUTICS, INC.
|
681,000 | $9,847,260 | |
| 8 | ABVX |
Abivax S.A.
|
81,496 | $9,074,579 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $602,853 | 45,090 | Shares | Sole | 2026-05-18 | |
| No filing history on record for this holder in this stock. | ||||||